<DOC>
	<DOCNO>NCT01533532</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety KLH-2109 patient endometriosis .</brief_summary>
	<brief_title>A Randomized , Placebo-controlled , Double-blind Study KLH-2109 Patients With Endometriosis ( 2 )</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<criteria>Female patient endometriosis Patients clinically significant hepatic , renal , cardiovascular dysfunction</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Gonadotropin-Releasing Hormone ( GnRH ) antagonist</keyword>
</DOC>